Features

Features Read the June 2018 Digital Edition

Read the June 2018 Digital Edition

The State of Diversity in Healthcare Marketing: For years, pharma has talked about diversity and inclusion issues in its midst, with some pundits saying the industry was slow to embrace diversity and others claiming that it's ahead of the curve.

Agencies AstraZeneca's Olivier Nataf on how his long tenure shapes his current role

AstraZeneca's Olivier Nataf on how his long tenure shapes his current role

AstraZeneca VP, head of U.S. oncology, Olivier Nataf details how being a company lifer impacted his career.

Agencies Two drugs in the pipeline representing unique marketing challenges

Two drugs in the pipeline representing unique marketing challenges

Two touted products in the pipeline reflect three of medical marketing's most profound modern-era challenges.

Corporate MSLs: 'We are the connectors'

MSLs: 'We are the connectors'

Meet "the connectors" as four of the best-regarded medical science liaisons and the leader of the MSL Society discuss what they do, how they do it, and why their work is so vital.

Agencies Tackling diversity and inclusion head-on

Tackling diversity and inclusion head-on

MM&M and Publicis Health debut results of their first Diversity Survey, detailing areas where healthcare agencies are progressing with regard to diversity and inclusion. Pharma leaders interviewed by MM&M say there are signs the industry is finally getting it right.

MMM Hall of Femme MM&M Hall of Femme 2018: The profiles

MM&M Hall of Femme 2018: The profiles

MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.

MMM Hall of Femme Meet the 2018 Women to Watch Honorees

Meet the 2018 Women to Watch Honorees

MM&M is honoring 20 Women to Watch, aspiring healthcare commercial and marketing execs changing the face of the industry.

Features Read the May 2018 Digital Edition

Read the May 2018 Digital Edition

Read the May 2018 issue in its entirety.

Features Evidence-based patient access programs

Evidence-based patient access programs

At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.

Agencies 4 agencies making a difference in their communities and around the world

4 agencies making a difference in their communities and around the world

Four agencies are making a difference by supporting nonprofits, educating and empowering youth, and promoting wellness and sustainability in communities around the world